Accordingly, a pathogenic loop between PCSK9 and inflammation (i.e., systemic inflammation induces PCSK9, which in turn promotes vascular inflammation) may be speculated, which may contribute to accelerated atherosclerosis in patients with rheumatic diseases. The gene discussed is PCSK9; the disease is rheumatic disorder.